Steven Glendon
Advises U.S. and non-U.S. corporate and financial institution clients on a wide variety of public and private capital markets and corporate transactions.
Steven advises U.S. and non-U.S. issuer and financial institution clients on a wide variety of public and private capital-raising transactions, corporate governance, SEC disclosure and general securities law and other corporate matters. He represents corporate and financial institution clients on initial public offerings and other equity offerings, private placements, investment-grade, high-yield and convertible debt issuances and liability management transactions.
Steven’s practice spans a broad range of industries, including aerospace, biotech, energy, financial services, fintech, industrials, insurance, retail and technology.
Experience
Recent Work
- Aktis Oncology $318 million IPO
- CoreWeave $2.6 billion convertible senior notes offering
- Eos Energy $458 million stock and $600 million convertible notes offerings
- BOKF $400 million subordinated notes offering
- Neptune $368 million IPO
- Albertsons $4 billion ABL extension
- Firefly Aerospace $1 billion IPO
- MP Materials $747.4 million follow-on offering
- Eos Energy $86 million stock offering and $225 million convertible notes offering
- Medallion Bank preferred stock offering
- Qualcomm $1.5 billion notes offering
- Synchrony Financial $800 million senior notes offering
- Leidos $1 billion notes offering and tender offer
- AbbVie $4 billion senior notes offering
- Genius Sports $150 million follow-on offering
- Bacardi $1 billion notes offering
Education
- Senior Production Editor, Virginia Law & Business Review
Prior experience
- White & Case, 2018-2021
Qualifications and admissions
- State of New York